These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15939704)

  • 21. A comprehensive approach for integration of toxicity and cancer risk assessments.
    Butterworth BE; Bogdanffy MS
    Regul Toxicol Pharmacol; 1999 Feb; 29(1):23-36. PubMed ID: 10051416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay.
    Cohen SM
    Toxicol Sci; 2004 Aug; 80(2):225-9. PubMed ID: 15129023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.
    Dellarco VL; McGregor D; Berry SC; Cohen SM; Boobis AR
    Crit Rev Toxicol; 2006; 36(10):793-801. PubMed ID: 17118729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk.
    Osimitz TG; Lake BG
    Crit Rev Toxicol; 2009; 39(6):501-11. PubMed ID: 19463055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of rodent carcinogenesis bioassays.
    Ward JM
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):212. PubMed ID: 18029286
    [No Abstract]   [Full Text] [Related]  

  • 29. Report of the Rodent Bladder Carcinogenesis Working Group.
    Food Chem Toxicol; 1995 Sep; 33(9):699-802. PubMed ID: 7557743
    [No Abstract]   [Full Text] [Related]  

  • 30. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
    Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 32. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Terminology of carcinogenesis in light of the current concepts of the mechanisms of action of chemical carcinogens].
    Khudoleĭ VV; Pliss GB; Schramm T
    Eksp Onkol; 1986; 8(5):63-74. PubMed ID: 3780516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemically induced preneoplastic lesions in rodents as indicators of carcinogenic activity.
    Williams GM
    IARC Sci Publ; 1999; (146):185-202. PubMed ID: 10353388
    [No Abstract]   [Full Text] [Related]  

  • 35. [Further comment on tumors of the rodent forestomach as an experimental model in the peroral administration of chemical carcinogens].
    Ianysheva NIa; Chernichenko IA; Balenko NV
    Gig Sanit; 1979 Jan; (1):77-80. PubMed ID: 761791
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of carcinogenic risk based on mode of drug action.
    Fujii T
    J Toxicol Sci; 1995 Sep; 20(4):459-61. PubMed ID: 8531241
    [No Abstract]   [Full Text] [Related]  

  • 37. A mechanistic interpretation of the oncogenicity of chlorothalonil in rodents and an assessment of human relevance.
    Wilkinson CF; Killeen JC
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):69-84. PubMed ID: 8921547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Children as a sensitive subpopulation for the risk assessment process.
    Preston RJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(2):132-41. PubMed ID: 15313585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data.
    Sielken RL; Stevenson DE
    Prog Clin Biol Res; 1992; 374():295-319. PubMed ID: 1620708
    [No Abstract]   [Full Text] [Related]  

  • 40. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.